Stay updated on Selonsertib for NASH F3 Fibrosis Clinical Trial

Sign up to get notified when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Selonsertib for NASH F3 Fibrosis Clinical Trial page

  1. Check
    6 days ago
    Change Detected
    Summary
    Added related topics: Non-alcoholic fatty liver disease and MedlinePlus Genetics to the page's related topics section.
    Difference
    0.0%
    Check dated 2025-10-26T04:37:47.000Z thumbnail image
  2. Check
    14 days ago
    Change Detected
    Summary
    Removed MedlinePlus Genetics topic: Non-alcoholic fatty liver disease.
    Difference
    0.1%
    Check dated 2025-10-18T00:08:40.000Z thumbnail image
  3. Check
    21 days ago
    No Change Detected
  4. Check
    28 days ago
    Change Detected
    Summary
    Major change: update to notice about funding lapse and operating status (core content and proper nouns) plus version bump to v3.2.0.
    Difference
    1%
    Check dated 2025-10-03T12:38:26.000Z thumbnail image
  5. Check
    36 days ago
    Change Detected
    Summary
    Updated to v3.1.0 and added a new genetics topic: Non-alcoholic fatty liver disease.
    Difference
    0.2%
    Check dated 2025-09-26T07:55:28.000Z thumbnail image
  6. Check
    43 days ago
    Change Detected
    Summary
    Removed the MedlinePlus Genetics topic: Non-alcoholic fatty liver disease, reducing coverage of that condition on the page.
    Difference
    0.1%
    Check dated 2025-09-19T04:59:16.000Z thumbnail image
  7. Check
    50 days ago
    Change Detected
    Summary
    Added a MedlinePlus Genetics topic: Non-alcoholic fatty liver disease, and updated the page revision from v3.0.1 to v3.0.2. The 'Back to Top' element was removed as a minor navigation change.
    Difference
    0.2%
    Check dated 2025-09-12T00:46:35.000Z thumbnail image

Stay in the know with updates to Selonsertib for NASH F3 Fibrosis Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Selonsertib for NASH F3 Fibrosis Clinical Trial page.